Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease

Aging Clinical and Experimental Research

Volumn 23, Issue 2, 2011, Pages 112-117

  Sosa, Manuel ^a   Saavedra, Pedro ^a   Gómez De Tejada, María Jesús ^a   Mosquera, José ^a   Pérez Cano, Ramón ^a   Olmos, José Manuel ^a   Muñoz Torres, Manuel ^a   Amérigo, María José ^a   Moro, María Jesús ^a   Díaz Curiel, Manuel ^a   Alegre, Javier ^a   Malouf, Jorge ^a   Del Pino, Javier ^a   Nogués, Xavier ^a   Torrijos, Antonio ^a   Castro, A ^b   Montoya Garcia, M J ^b   Vazquez Gamez M A ^b   Valero, C ^b   Gonzalez Maclas J ^b   Alonso, G ^b   Mao, L ^b   Nunez J J ^b   Pastor Palnas, A ^b   Garcia Arias, M ^b   Farrerons Minguella, J ^b   Diez Perez A ^b   Quintana, E ^b   Hemandez Hemandez D ^b   more..

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b NONE

Author keywords

Atherosclerosis; Beta blockers; Bone mineral density; Coronary heart disease; Fracture; Osteoporosis; Quantitative ultrasound

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG UTILIZATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FEMUR NECK; FRAGILITY FRACTURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; QUANTITATIVE ANALYSIS; VERTEBRA FRACTURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGING; BODY MASS INDEX; BONE DENSITY; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; FRACTURES, BONE; HUMANS; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 79960923820     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.3275/7041     Document Type: Article

References (39)

1. Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Athyros VG, Mikhailidis DP. Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int 2009; 20: 197-207.
2. Von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999; 106: 273-8.
3. Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 2000; 15: 1974-80.
4. Marcovitz PA, Tran HH, Franklin BA et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 2005; 96: 1059-63. (Pubitemid 41416595)
5. Warburton DE, Nicol CW, Gatto SN, Bredin SS. Cardiovascular disease and osteoporosis: balancing risk management. Vasc Health Risk Manag 2007; 3: 673-89.
6. Cummings SR, Black DM, Nevitt MC et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993; 341: 72-5.
7. Gluer CC, Barkmann R. Quantitative ultrasound: use in the detection of fractures and in the assessment of bone composition. Curr Osteoporos Rep 2003; 1: 98-104.
8. Gluer CC, Eastell R, Reid DM et al. Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res 2004; 19: 782-93.
9. Hirose K, Tomiyama H, Okazaki R et al. Increased pulse wave velocity associated with reduced calcaneal quantitative osteo-sono index: possible relationship between atherosclerosis and osteopenia. J Clin Endocrinol Metab 2003; 88: 2573-8.
10. Hofle G, Saely CH, Tautermann G, Aczel S, Holzmuller H, Drexel H. Relationship between various measures of bone mineral density and vertebral fractures in cardiac transplant recipients. Swiss Med Wkly 2004; 134: 215-20.
11. Paakkunainen U, Raittinen P, Viikari J, Seppanen R, Simell O. The impact of low-saturated fat, low cholesterol diet on bone properties measured using calcaneal ultrasound in prepubertal children. Calcif Tiss Int 2002; 71: 219-26.
12. Diaz-Guerra GM, Gil-Fraguas L, Jodar E, et al. Quantitative ultrasound of the calcaneus in long-term liver or cardiac transplantation patients. J Clin Densitom 2006; 9: 469-74.
13. Research on the menopause in the 1990s. Report of a WHO Scientific Group. World Health Organization technical report series 1996; 866: 1-107.
14. Sosa M, Saavedra P, Munoz-Torres M et al. Quantitative ultrasound calcaneus measurements: normative data and precision in the Spanish population. Osteoporos Int 2002; 13: 487-92.
15. Diaz Curiel M, Carrasco de la Pena JL, Honorato Perez J, Perez Cano R, Rapado A, Ruiz Martinez I. Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis. Osteoporos Int 1997; 7: 59-64.
16. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-48. (Pubitemid 23261108)
17. Cummings SR, Block G, McHenry K, Baron RB. Evaluation of two food frequency methods of measuring dietary calcium intake. Am J Epidemiol 1987; 126: 796-802. (Pubitemid 17161303)
18. Tarantino U, Cannata G, Lecce D, Celi M, Cerocchi I, Iundusi R. Incidence of fragility fractures. Aging Clin Exp Res 2007; 19 (Suppl. 4): 7-11.
19. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. Southern Med J 2001; 94: 569-73.
20. Aronow WS. Silent MI. Prevalence and prognosis in older patients diagnosed by routine electrocardiograms. Geriatrics 2003; 58: 24-6, 36-8, 40.
21. Jackson R, Scragg R, Beaglehole R. Alcohol consumption and risk of coronary heart disease. BMJ 1991; 303: 211-6.
22. Browner WS, Seeley DG, Vogt TM, Cummings SR. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 1991; 338: 355-8.
23. Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005; 20: 1912-20.
24. Turker S, Karatosun V, Gunal I. Beta-blockers increase bone mineral density. Clin Orthop Rel Res 2006; 443: 73-4.
25. Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 2004; 19: 19-24.
26. Levasseur R, Dargent-Molina P, Sabatier JP, Marcelli C, Breart G. Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidémiologie de l'Ostéoporose prospective study. J Am Geriatr Soc 2005; 53: 550-2.
27. Reid IR, Gamble GD, Grey AB et al. Beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res 2005; 20: 613-8. (Pubitemid 40393069)
28. de Vries F, Souverein PC, Cooper C, Leufkens HG, van Staa TP. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tiss Int 2007; 80: 69-75. (Pubitemid 46294972)
29. Meisinger C, Heier M, Lang O, Doring A. Beta-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study. Osteoporos Int 2007; 18: 1189-95. (Pubitemid 47300270)
30. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of beta-blockers and risk of fractures. JAMA 2004; 292: 1326-32.
31. Wiens M, Etminan M, Gill SS, Takkouche B. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med 2006; 260: 350-62.
32. Perez-Castrillon JL, Vega G, Abad L et al. Effect of beta-blockers on bone mass and biomechanical parameters of the femoral neck in males with acute myocardial infarction. Joint Bone Spine 2007; 74: 259-62. (Pubitemid 46720049)
33. de Vries F, Pouwels S, Bracke M et al. Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Safety 2007; 16: 612-9. (Pubitemid 47039527)
34. Reid IR. Effects of beta-blockers on fracture risk. J Musculoskelet Neuronal Interact 2008; 8: 105-10.
35. Rejnmark L. Cardiovascular drugs and bone. Current Drug Safety 2008; 3: 178-84.
36. Haguenauer D, Welch V, Shea B, Tugwell P, Wells G. Fluoride for treating postmenopausal osteoporosis. Cochrane Database Syst Rev (online). 2000(4): CD002825.
37. Agnusdei D. Bone quality. Aging Clin Exp Res 2004; 16 (Suppl. 3): 1-2.
38. Maggi S, Lauretani F, Ferrucci L et al. The quality of bone: a "magic natural alloy". Aging Clin Exp Res 2004; 16 (Suppl. 3): 3-9.
39. Sosa M, Saavedra P, Jodar E et al. Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study. Aging Clin Exp Res 2009; 21: 27-32.